Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
2019 · British Journal of Cancer · 60 citations
https://doi.org/10.1038/s41416-019-0609-0